| SPECIAL REPORT: EMPLOYMENT SURVEY |
Rita C. Peters
Keeping valuable employees happy—and on the job—may test bio/pharma business decisions.
read more
| API SYNTHESIS & MANUFACTURING |
Cynthia A. Challener
Orphan and cancer drugs continue to lead, but treatments for many common diseases were also approved in 2018.
read more
| FORMULATION |
Felicity Thomas
New approaches seek to address formulation and delivery challenges for these complex molecules.
read more
| BIOPHARMACEUTICAL MANUFACTURING |
Birte Kleindienst, Peter Kosiol, Anika Manzke
Requirements for virus filtration must be considered in developing continuous downstream processes.
read more
| PEER-REVIEWED RESEARCH |
Yasvanth Ashokraj, Swati Laud, Kalpesh Sawant, Prashant Modak, Praveen Date
This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.
read more
| REGULATORY UPDATE |
Agnes Shanley
This year promises to bring more focus on risk management and building a quality culture, says consultant Susan Schniepp.
read more
| ANALYTICS: SOLUBILITY |
Felicity Thomas
Early adoption of the right approach to address solubility can deliver significant benefits.
read more
| PACKAGING |
Hallie Forcinio
Active and intelligent packaging technologies benefit brand owners, caregivers, and patients.
read more
| FROM THE EDITOR |
Rita C. Peters
Pricing pressures, investment volatility, and government disfunction greet Pharma in 2019.
read more
| OUTSOURCING OUTLOOK |
By Eric Langer, Ronald A. Rader
Outsourcing of manufacturing activities is expected to increase in 2019.
read more
| US REGULATORY WATCH |
Jill Wechsler
FDA plans to support initiatives to ensure that all medicines are safe, effective, and of high quality.
read more
| ASK THE EXPERT |
Siegfried Schmitt
Understanding the differences in inspection processes is the key to successful global expansion, according to Siegfried Schmitt, PhD, vice-president Technical, PAREXEL Consulting.
read more
|
